Objective: To examine the use of fecal occult blood testing in inpatients and in those presenting to the emergency department.
Although the usefulness of fecal occult blood tests (FOBTs) is occasionally questioned, they continue to be widely used in a number of settings, including as part of the physical examination during inpatient stay and at hospital admission. 1 FOBT assays are designed to detect hemoglobin molecules in fecal specimens as an indication of gastrointestinal (GI) bleeding that can be due to various pathologies, including GI inflammation 1, 4 and CRC. 5 Guaiac-based FOBTs use the peroxidase-like activity of the heme molecule in hemoglobin, in the presence of hydrogen peroxide, to catalyze the oxidation of alpha-guaiaconic acid to a blue-colored quinone compound. An upper GI bleed is only detected by heme-based assays. Newer, more sensitive, and more specific antibody-based assays, such as fecal immunochemical testing (FIT), do not detect upper GI bleeds because the antigen (hemoglobin) will be digested and epitopes lost during GI passage.
The role of 3 sequential FOBTs in screening for CRC is well documented, [6] [7] [8] [9] and multisociety guidelines for early detection of CRC include their use. 10 Two specimens are adequate for CRC screening with the newer, more sensitive FIT. However, there is little evidence for the appropriate use of single guaiac-based FOBTs among hospitalized patients.
In the era of evidence-based medicine, continued usage of guaiac-based FOBTs must be assessed in terms of outcomes. Ideally, test results should affect patient management. In the case of a positive FOBT result, standard texts recommend that a clinical assessment and a GI investigation, such as endoscopy, should follow. The selection of esophagogastroduodenoscopy (EGD) to examine the uppermost third of the GI tract vs colonoscopy to examine the lowermost third of the GI tract vs both procedures usually is dependent on other findings in the patient history and physical examination. This study examines patient management (endoscopic studies) after obtaining guaiac-based FOBTs during hospitalization or in the emergency department (ED).
Materials and Methods
Subject individuals were inpatients and patients who presented to the ED who were undergoing investigation at a county health care facility, Parkland Memorial Hospital (Parkland Health and Hospital System [PHHS] ). This hospital is a 900-bed tertiary-care teaching hospital affiliated with the University of Texas Southwestern Medical Center, Dallas, TX.
Data Collection
The laboratory information system Cerner Millennium (Cerner Corporation) and electronic health record (EHR) system (Epic Systems Corporation) were queried for list 
Endoscopy Scheduled Within 30 Days of FOBT Results
We limited further analysis to results with an endoscopy order placed from 0 to 30 days after the date of the FOBT result, reasoning that these were the most likely to be related to the test results. (This interval allowed ample time for result availability and clinical provider response, after review of abnormal FOBT results, flagged in the EHR). We excluded orders that were canceled and for which the procedure was other than EGD or colonoscopy.
The reason for the procedure order and the results of the procedure were analyzed for the remaining 957 procedures. EGD and colonoscopy reasons were analyzed separately because the reasons for the procedure were often disparate.
Categorization of Endoscopic Procedures
We manually reviewed the endoscopy procedure notes and recorded the reason(s) for ordering the procedure and the findings. Keywords were identified and used to classify each procedure with a discrete reason. When multiple reasons were given, the major categories were hierarchical. The category more or most likely to be associated with a positive FOBT result and/or finding via endoscopy was selected.
Regarding reasons for ordering, the discrete category hierarchy was GI bleeding including positive FOBT result (n = 388), iron-deficiency anemia (n = 146), anemia (n = 103), nausea/vomiting/diarrhea (n = 102), and abdominal pain (n = 31). The category "other" (n = 190) was selected for one or more reasons other than those in the hierarchy when by itself or in combination with one of the discrete categories. The other reasons are provided in the footnotes to Table 1 and Table 2 .
Statistical Analysis
We performed comparisons of reasons for endoscopy and endoscopic findings between FOBT-result groups. Continuous variables displayed as mean (SD) for normally distributed data and were compared using the 
Results
Between January 1, 2010 and December 31, 2012, there were 5028 results for FOBTs using guaiac-based Hemoccult Sensa (Beckman Coulter Inc), reported by the chemistry laboratory of PHHS ( Figure 1 ). There were more negative results than positive ones: 3571 negative (71.0%) vs 1457 positive (29.0%); 2582 subjects had only negative results (68.2%), whereas 1205 had at least 1 positive result. With the exception of race, the demographics were identical for those with positive and negative results (age, sex, and ethnicity). There were more white patients with positive results and more African American patients with negative results (χ 2 = 13.5, P = .02). Most of the FOBTs were obtained for inpatients on general medicine services (80.2%).
FOBT Results and Endoscopy
Medical management after obtaining FOBT results was determined by analyzing the GI procedures performed. Overall, 1740 GI procedures were scheduled for the subjects during a minimum of 12 months after FOBT results; 1009 (58.0%) of the associated FOBTs had yielded negative results. EGD was the procedure order associated with 1065 FOBT results, and 675 (38.7%) were for a colonoscopy, of which 468 results were associated with EGD and colonoscopy orders (Figure 2) . Most of the patients (71.4%) with at least 1 positive FOBT result did not have an associated procedure ordered or scheduled within the 12-monthsor-longer period afterwards.
Reasons for EGD Order
The reasons for scheduling an EGD were manually extracted from the EHR (Figure 3, Table 1 ). A positive FOBT result was a reason for scheduling an EGD in only 7 patients; none were found to have cancer. In 2 other patients, FOBT results were included in the reason for ordering EGD despite a negative test result. Anemia or iron deficiency was also in the reason for EGD ordering in 8 of 11 instances. We compared the FOBT result with the reason for scheduling an EGD. The reasons for ordering the EGD were statistically significantly different, depending on the FOBT result ( χ 2 = 73, P <.001). The FOBT result was also significantly more likely to be positive when comparing bleeding as the reason for EGD (overt or occult) vs all other reasons ( 
Reasons for Colonoscopy Order
Similarly, we categorized the reasons for scheduling a colonoscopy ( Figure 4 , Table 2 ). The reasons for colonoscopy included a positive FOBT result in 12 patients (20 tests), with a second reason in 8 of those patients (anemia, iron-deficiency anemia, IBD, or a history of metastases). We analyzed whether the reasons for scheduling a 
Figure 3
Reasons for scheduling esophagogastroduodenoscopy (EGD) within 30 days of fecal occult blood test (FOBT) result. Other refers to weight loss, possible cancer on imaging, gastrointestinal mass, unknown primary, previous cancer diagnosis, failure to thrive, bowel obstruction, history of inflammatory bowel disease (IBD), infectious colitis, possible strongyloides, after operation for diverticulitis, possible inflammation on imaging.
colonoscopy differed depending on the FOBT result. When we compared all reasons, there was a statistically significant difference in the distribution of categories between positive and negative FOBT results ( Figure 4 ; χ 2 = 52.9, P <.001). There were 124 test results involving occult or overt bleeding as the reason for the procedure (FOBT with positive result in 74.2%).
Long-Term Outcomes
There were 45 newly identified diagnoses of GI-tract cancer made in the 33+ months after the date of FOBT results. Most patients (28/45) were diagnosed at endoscopy ordered within 30 days of FOBT result. Of those not diagnosed at endoscopy ordered within 30 days, 8 patients with positive FOBT results had data matching those from the Cancer Registry: 2 patients with ileal lymphoma, 1 with a duodenal carcinoid tumor, and 6 with CRC. In all but 2 instances, an endoscopic procedure was ordered within 30 days after the positive FOBT result but not completed. Reasons for lack of completion included failure of the patient to schedule the procedure (n = 3); negative surveillance colonoscopy result on the same day as the positive FOBT result (n = 1); negative screening colonoscopy result 6 and 9 months before FOBT (n = 1); and admitted with acute liver failure, transferred to another hospital (n = 1).
Discussion
In this study, we critically reviewed the use of guaiac-based FOBTs in hospitalized patients and patients admitted to the ED. Our retrospective analysis of patient medical records comprises a 3-year cohort with FOBT results, GI endoscopic investigations for 4 years, and outcome follow-up for at least another 33 months. In the final analysis, there were 957 FOBT tests (677 patients) with upper-GI endoscopy or colonoscopy ordered within 30 days of initial FOBT results. Endoscopic procedures ordered after 711 test results (535 patients) were completed. Long-term follow-up resulted in a new diagnosis of cancer in 9 patients with at least 1 positive FOBT result after intervals of 36 to 1558 days. All but 2 had an endoscopy procedure ordered within 30 days of the positive FOBT result. Reasons for scheduling colonoscopy within 30 days of fecal occult blood test (FOBT) result. Other refers to weight loss, possible cancer on imaging, gastrointestinal mass, unknown primary, previous cancer diagnosis, failure to thrive, bowel obstruction, history of inflammatory bowel disease (IBD), infectious colitis, possible strongyloides, after surgery for diverticulitis, possible inflammation on imaging.
We conclude that FOBT results are not used in the management of hospitalized patients and those treated in the ED, and that most patients with a positive result in these settings do not undergo a timely follow-up procedure. Indeed, a positive FOBT was the sole reason for EGD and colonoscopy in only 1 patient and for colonoscopy in 3 other patients. By analyzing all test results, positive and negative, we provide evidence of management in both patient groups that is not otherwise available in the literature, to our knowledge. The reasons for scheduling and completing endoscopic procedures were clinical (in 99% of patients for EGD and 96% of patients for colonoscopy).
When FOBTs are used in symptomatic patients, however, the tests are considered diagnostic for the presence of GI bleeding. Few studies address the usefulness of those tests for diagnosis. [11] [12] [13] The sensitivity of FOBTs was insufficient in patients with GI symptoms (changed bowel habit or history suggestive of melena) or iron-deficiency anemia to recommend its use. 11 In patients with GI inflammation,
FOBT results were positive in 3.5%, which was not widely different from the rate in controls (2.1%). 12 Also, FOBTs cannot distinguish infectious diarrhea from noninfectious diarrhea. 13 Recently, a number of authors 2,14-16 have criticized the overuse or misuse of FOBTs in the hospital setting. The findings reported by others are similar to the data presented herein. For example, a study at a Veterans Affairs hospital in New York City investigated 1342 FOBTs and found that almost one-third of positive results were not investigated further. 14 In the Netherlands, the results of review of a subset of medical records (n = 201) demonstrated that FOBTs were scheduled for patients with anemia (41%), suspicion of rectal bleeding (17%), abdominal pain (14%), change in bowel habits (10%), and other reasons (18%). 15 One-third of patients had a positive result. To our knowledge, this is the largest inpatient and ED review in the literature, with more than 5000 FOBT results and more than 12,000 endoscopy procedures scheduled during the study period. Data for EGD and colonoscopy procedures were collected during a 4-year period to allow for any anticipated delay after FOBT results. Although limited to 1 institution, our findings mirror those of other studies.
Changing the practices of health care providers can be challenging. Our study was performed to provide the evidence needed for the assertion that FOBTs were not used for management in these settings. Thus, clinical presentation was superior to FOBT results in predicting findings at endoscopy.
In conclusion, testing for fecal occult blood should be limited to screening for CRC using the most sensitive, specific, easy-to-use methodology. The Emergency Services Department at Parkland no longer uses routine diagnostic FOBTs for GI bleed. It may be time to change the standard approach on the inpatient services also, where resistance to the use of FOBTs is encountered. This report provides evidence for those wishing to embark on the practice of limiting use of FOBTs. LM
